Abbott’s newly created diversity in research office is providing resources and support for patients and clinicians to help diversify the company’s clinical trials.
Jennifer Jones-McMeans, Abbott’s divisional vice president of global clinical affairs, told Medtech Insight that Abbott plans to spend $5m on the initiative over the next five years.